EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Attenuation of a Novel Goose Parvovirus Strain NMG21 via Serial Cell Passage

Jing Yang, Dalin He, Bingrong Wu, Yun Yan, Yupei Zhang, Jiaping Zhou, Feng Wei iD, Youjiang Diao

Viruses · 2025

DOI: 10.3390/v17050618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Jing Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Agricultural Science and Technology, Shandong Agriculture and Engineering University, Ji'nan 250100, China. Hauptthemen laut MEDLINE: Parvoviridae Infections, Poultry Diseases, Parvovirinae, Parvovirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Shandong Province, Shandong Agriculture and Engineering University Start-Up Fund for Talented Scholars, The Postdoctoral Fellowship Program of CPSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel goose parvovirus (N-GPV), responsible for beak atrophy and dwarfism syndrome (BADS), has caused significant economic losses in China’s duck-raising industry. In this study, a highly virulent N-GPV strain NMG21 was serially passaged in duck embryo fibroblast cells (DEFs). The virus titers and virulence of selected passages were evaluated in 1-day-old ducklings. An increased virus titer was observed at the 5th passage (P5). Compared with the parent strain NMG21, the P35 (NMG21-35 strain) has a clear decrease in pathogenicity for ducklings, with less tissue damage. The NMG21-35 also exhibited relatively lower tissue replication rates and higher antibody levels. Collectively, the virulence of N-GPV strain NMG21 was reduced via serial passage in DEFs for 35 passages. Our research successfully prepared a N-GPV attenuated variant which might serve as a potential live vaccine candidate against N-GPV infection. Developing a live attenuated vaccine candidate against N-GPV infection in China is crucial for mitigating the economic impact of N-GPV on the duck industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parvoviridae InfectionsPoultry DiseasesParvovirinaeParvovirusAnimalsDucksGeeseSerial PassageFibroblastsVirulenceAntibodies, ViralChinaVaccines, AttenuatedVirus Replication

Stichwörter der Autor:innen

BADSDEFsN-GPVpathogenicityvirulence

Substanzen

Antibodies, ViralVaccines, Attenuated

Autor:innen und Institutionen

  • College of Agricultural Science and Technology, Shandong Agriculture and Engineering University, Ji'nan 250100, China.
  • College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China.

ORCID-Profile: Feng Wei

Förderung

  • Key Research and Development Program of Shandong Province
  • Shandong Agriculture and Engineering University Start-Up Fund for Talented Scholars
  • The Postdoctoral Fellowship Program of CPSF
  • The Innovation Leading Team Program of Guangzhou City
  • China Agriculture Research System of MOF and MARA
  • Postdoctoral Fellowship Program of CPSF
  • Innovation Leading Team Program of Guangzhou City

Zitieren

APA

Yang, J., He, D., Wu, B., Yan, Y., Zhang, Y., Zhou, J., Wei, F., & Diao, Y. (2025). Attenuation of a Novel Goose Parvovirus Strain NMG21 via Serial Cell Passage. Viruses. https://doi.org/10.3390/v17050618

Vancouver

Yang J, He D, Wu B, Yan Y, Zhang Y, Zhou J, et al. Attenuation of a Novel Goose Parvovirus Strain NMG21 via Serial Cell Passage. Viruses. 2025. doi:10.3390/v17050618

BibTeX
@article{Yang2025,
  author = {Yang, Jing and He, Dalin and Wu, Bingrong and Yan, Yun and Zhang, Yupei and Zhou, Jiaping and Wei, Feng and Diao, Youjiang},
  title = {Attenuation of a Novel Goose Parvovirus Strain NMG21 via Serial Cell Passage},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17050618}
}
Kostenlos starten →